UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Correction: Gallus et al. Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma. Cancers 2023, 15 , 3726

Cancers, 2023-12, Vol.16 (1), p.119

2023

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma

Cancers, 2023-07, Vol.15 (14), p.3726

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of cancer-specific anti-podoplanin CAR-T cells and oncolytic herpes virus G47Δ combination therapy against glioblastoma

Molecular therapy. Oncolytics, 2022-09, Vol.26, p.265-274

2022

Link zum Volltext

Verfügbarkeit prüfen

Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas

Brain tumor pathology, 2022-01, Vol.39 (1), p.14-24

2022

Link zum Volltext

Verfügbarkeit prüfen

Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma

Scientific reports, 2024-03, Vol.14 (1), p.6362-6362

2024

Link zum Volltext

Verfügbarkeit prüfen

843 Intra-cerebral spinal fluid vaccination to facilitate antigen-specific T-cell responses in the CNS tumors

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A942-A942

2023

Link zum Volltext

Verfügbarkeit prüfen

Pathogenic Epigenetic Consequences of Genetic Alterations in IDH-Wild-Type Diffuse Astrocytic Gliomas

Cancer research (Chicago, Ill.), 2019-10, Vol.79 (19), p.4814-4827

2019

Link zum Volltext

Verfügbarkeit prüfen

Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al

Journal for immunotherapy of cancer, 2023-03, Vol.11 (3), p.e006617

2023

Link zum Volltext

Verfügbarkeit prüfen

A novel high-sensitivity assay to detect a small fraction of mutant IDH1 using droplet digital PCR

Brain tumor pathology, 2018-04, Vol.35 (2), p.97-105

2018

Link zum Volltext

Verfügbarkeit prüfen

956 Glioma-neuronal circuit remodeling induces regional immunosuppression

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1062-A1063

2023

Link zum Volltext

Verfügbarkeit prüfen

277 SynNotch-CAR T cells demonstrate potent anti-tumor efficacy in a preclinical immunocompetent mouse model for glioblastoma

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A317-A317

2023

Link zum Volltext

Verfügbarkeit prüfen

Immunohistochemical ATRX expression is not a surrogate for 1p19q codeletion

Brain tumor pathology, 2018-04, Vol.35 (2), p.106-113

2018

Link zum Volltext

Verfügbarkeit prüfen

144 Novel public and tumor-wide neoantigens arising from clonal aberrant splicing events drive tumor-specific T-cell responses across diverse cancer types

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A164-A164

2023

Link zum Volltext

Verfügbarkeit prüfen

A novel all-in-one intraoperative genotyping system for IDH1-mutant glioma

Brain tumor pathology, 2017-04, Vol.34 (2), p.91-97

2017

Link zum Volltext

Verfügbarkeit prüfen

An immuno-wall microdevice exhibits rapid and sensitive detection of IDH1-R132H mutation specific to grade II and III gliomas

Science and technology of advanced materials, 2016-01, Vol.17 (1), p.618-625

2016

Link zum Volltext

Verfügbarkeit prüfen

Correction: Gallus et al. Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma. ICancers/I 2023, I15/I, 3726

Cancers, 2023-12, Vol.16 (1)

2023

Link zum Volltext

Verfügbarkeit prüfen

Tumor antigens in glioma

Seminars in immunology, 2020-02, Vol.47, p.101385-101385, Article 101385

2020

Link zum Volltext

Verfügbarkeit prüfen

IMMU-52. LOW-INTENSITY PULSED ULTRASOUND CONDUCTS ANTIGEN-INDEPENDENT T CELL HOMING INTO THE BRAIN PARENCHYMA WITH THE INTACT BLOOD-BRAIN BARRIER

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v154-v154

2023

Link zum Volltext

Verfügbarkeit prüfen

EXTH-06. PRE-INFUSION METABOLIC MODULATION OF CAR-T CELLS PROMOTES THE RESISTANCE TO THE SUPPRESSIVE EFFECTS OF HYPOXIA AND ENHANCES ANTI-TUMOR EFFECTS AGAINST INTRACEREBRAL GLIOMAS

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii209-vii210

2022

Link zum Volltext

Verfügbarkeit prüfen

IMMU-04. LOW-INTENSITY PULSED ULTRASOUND ENHANCES CAR T CELL THERAPY BY INDUCING TWO-WAY IMMUNE CELL TRAFFICKING – T CELL INTO TUMOR AND MYELOID CELL INTO PERIPHERY IN A SYNGENEIC MOUSE GLIOBLASTOMA MODEL

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v141-v142

2023

Link zum Volltext

Verfügbarkeit prüfen

IMMU-45. CAR-T TREATMENT OF NOVEL MOUSE MODEL OF EGFRVIII+ GBM MIRRORS CLINICAL TRIAL OUTCOMES AND PROVIDES A SYNGENEIC PLATFORM FOR THE INVESTIGATION OF CAR-T MECHANISMS OF ACTION

Neuro-oncology (Charlottesville, Va.), 2019-11, Vol.21 (Supplement_6), p.vi128-vi129

2019

Link zum Volltext

Verfügbarkeit prüfen

CNSC-06. REDIRECTING IMMUNOSUPPRESSIVE GLIOMA MICROENVIRONMENT THROUGH PHARMACOLOGICAL INTERVENTION TARGETING NEURONAL ACTIVITY

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v23-v23

2023

Link zum Volltext

Verfügbarkeit prüfen

EXTH-18. DEVELOPMENT OF A TRANSGENIC MOUSE MODEL ENABLING COMPARATIVE ANALYSIS OF CHIMERIC ANTIGEN RECEPTOR (CAR)-EXPRESSING IMMUNE CELL POPULATIONS FOR CANCER IMMUNOTHERAPY

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v227-v227

2023

Link zum Volltext

Verfügbarkeit prüfen

IMMU-08. NOVEL NANOPARTICLE-BASED DELIVERY OF H3.3K27M PEPTIDE TO TUMOR-ASSOCIATED MACROPHAGES ENHANCES THE TUMOR HOMING OF H3.3K27M-TCR TRANSDUCED T-CELLS IN HLA-A2/DR1 TRANSGENIC MICE WITH H3.3K27M

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi93-vi93

2021

Link zum Volltext

Verfügbarkeit prüfen

IMMU-21. LOW-INTENSITY PULSED ULTRASOUND PROMOTES THE PRESENTATION OF BRAIN-DERIVED ANTIGENS THROUGH ENHANCED TRAFFICKING OF ANTIGEN-PRESENTING CELLS FROM THE BRAIN INTO THE PERIPHERY

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v146-v146

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(47)
Berichte
(1)

Sprache

Englisch
(44)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Neuro-Oncology
(14)
Journal For Immunotherapy Of Cancer
(6)
Brain Tumor Pathology
(4)
Cancer Research
(4)
Cancers
(3)
Journal Of Neuroendovascular Therapy
(3)
Apoptosis
(1)
Cancer Immunology Research
(1)
Cancer Investigation
(1)
Cancer Res
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Correction: Gallus et al. Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma. Cancers 2023, 15 , 3726

Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma

Efficacy of cancer-specific anti-podoplanin CAR-T cells and oncolytic herpes virus G47Δ combination therapy against glioblastoma

Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas

Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma

843 Intra-cerebral spinal fluid vaccination to facilitate antigen-specific T-cell responses in the CNS tumors

Pathogenic Epigenetic Consequences of Genetic Alterations in IDH-Wild-Type Diffuse Astrocytic Gliomas

Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al

A novel high-sensitivity assay to detect a small fraction of mutant IDH1 using droplet digital PCR

956 Glioma-neuronal circuit remodeling induces regional immunosuppression

277 SynNotch-CAR T cells demonstrate potent anti-tumor efficacy in a preclinical immunocompetent mouse model for glioblastoma

Immunohistochemical ATRX expression is not a surrogate for 1p19q codeletion

144 Novel public and tumor-wide neoantigens arising from clonal aberrant splicing events drive tumor-specific T-cell responses across diverse cancer types

A novel all-in-one intraoperative genotyping system for IDH1-mutant glioma

An immuno-wall microdevice exhibits rapid and sensitive detection of IDH1-R132H mutation specific to grade II and III gliomas

Correction: Gallus et al. Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma. ICancers/I 2023, I15/I, 3726

Tumor antigens in glioma

IMMU-52. LOW-INTENSITY PULSED ULTRASOUND CONDUCTS ANTIGEN-INDEPENDENT T CELL HOMING INTO THE BRAIN PARENCHYMA WITH THE INTACT BLOOD-BRAIN BARRIER

EXTH-06. PRE-INFUSION METABOLIC MODULATION OF CAR-T CELLS PROMOTES THE RESISTANCE TO THE SUPPRESSIVE EFFECTS OF HYPOXIA AND ENHANCES ANTI-TUMOR EFFECTS AGAINST INTRACEREBRAL GLIOMAS

IMMU-04. LOW-INTENSITY PULSED ULTRASOUND ENHANCES CAR T CELL THERAPY BY INDUCING TWO-WAY IMMUNE CELL TRAFFICKING – T CELL INTO TUMOR AND MYELOID CELL INTO PERIPHERY IN A SYNGENEIC MOUSE GLIOBLASTOMA MODEL

IMMU-45. CAR-T TREATMENT OF NOVEL MOUSE MODEL OF EGFRVIII+ GBM MIRRORS CLINICAL TRIAL OUTCOMES AND PROVIDES A SYNGENEIC PLATFORM FOR THE INVESTIGATION OF CAR-T MECHANISMS OF ACTION

CNSC-06. REDIRECTING IMMUNOSUPPRESSIVE GLIOMA MICROENVIRONMENT THROUGH PHARMACOLOGICAL INTERVENTION TARGETING NEURONAL ACTIVITY

EXTH-18. DEVELOPMENT OF A TRANSGENIC MOUSE MODEL ENABLING COMPARATIVE ANALYSIS OF CHIMERIC ANTIGEN RECEPTOR (CAR)-EXPRESSING IMMUNE CELL POPULATIONS FOR CANCER IMMUNOTHERAPY

IMMU-08. NOVEL NANOPARTICLE-BASED DELIVERY OF H3.3K27M PEPTIDE TO TUMOR-ASSOCIATED MACROPHAGES ENHANCES THE TUMOR HOMING OF H3.3K27M-TCR TRANSDUCED T-CELLS IN HLA-A2/DR1 TRANSGENIC MICE WITH H3.3K27M

IMMU-21. LOW-INTENSITY PULSED ULTRASOUND PROMOTES THE PRESENTATION OF BRAIN-DERIVED ANTIGENS THROUGH ENHANCED TRAFFICKING OF ANTIGEN-PRESENTING CELLS FROM THE BRAIN INTO THE PERIPHERY

Suchergebnisse filtern